KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elevance Health (ELV) Profit After Tax (2016 - 2025)

Elevance Health (ELV) has disclosed Profit After Tax for 17 consecutive years, with $546.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Profit After Tax rose 33.5% to $546.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.7 billion, a 5.19% decrease, with the full-year FY2025 number at $5.7 billion, down 5.19% from a year prior.
  • Profit After Tax was $546.0 million for Q4 2025 at Elevance Health, down from $1.2 billion in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of $2.3 billion in Q2 2024 to a low of -$44.4 billion in Q4 2021.
  • A 5-year average of -$793.3 million and a median of $1.6 billion in 2022 define the central range for Profit After Tax.
  • Biggest YoY gain for Profit After Tax was 576.58% in 2021; the steepest drop was 8149.55% in 2021.
  • Elevance Health's Profit After Tax stood at -$44.4 billion in 2021, then surged by 101.84% to $818.0 million in 2022, then rose by 1.59% to $831.0 million in 2023, then plummeted by 50.78% to $409.0 million in 2024, then soared by 33.5% to $546.0 million in 2025.
  • Per Business Quant, the three most recent readings for ELV's Profit After Tax are $546.0 million (Q4 2025), $1.2 billion (Q3 2025), and $1.7 billion (Q2 2025).